Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetics and Heart Health After Cancer Therapy

NCT03510689 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT03510689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03510689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetics and Heart Health After Cancer Therapy
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Completed
Start date
December 5, 2017
Completion date
May 31, 2022
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, drug-induced cardiomyopathy, heart diseases, hereditary breast/ovarian cancer (brca1, brca2)